Brand
Differin
Differin Adapalene Gel was a prescription-only medication from 1996 until the FDA approved its OTC switch in July 2016, making it the first and only prescription-strength retinoid available without a prescription. The approval was based on 20 years of safety data from over 40 million patients globally. Manufactured by Galderma, a global dermatology company with R&D headquarters in Sophia Antipolis, France.
In Catalog
9